000			01882 a2200541 4500
005			20250513144019.0
264		0	_c19980624
008			199806s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm980076u _2doi
040			_aNLM _beng _cNLM
100	1		_aMonte, A P
245	0	0	_aSubstituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity. _h[electronic resource]
260			_bJournal of medicinal chemistry _cJun 1998
300			_a2134-45 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aBinding, Competitive
650	0	4	_aBrain _xmetabolism
650	0	4	_aCell Line
650	0	4	_aCricetinae
650	0	4	_aDiscrimination Learning _xdrug effects
650	0	4	_aErgolines _xchemistry
650	0	4	_aFurans _xchemical synthesis
650	0	4	_aHallucinogens _xchemical synthesis
650	0	4	_aHumans
650	0	4	_aLysergic Acid Diethylamide _xpharmacology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMuscarinic Antagonists _xchemical synthesis
650	0	4	_aPhenethylamines _xchemistry
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Muscarinic _xmetabolism
650	0	4	_aReceptors, Serotonin _xmetabolism
650	0	4	_aRecombinant Proteins _xmetabolism
650	0	4	_aStereoisomerism
650	0	4	_aStructure-Activity Relationship
650	0	4	_aTetrahydronaphthalenes _xchemical synthesis
700	1		_aMarona-Lewicka, D
700	1		_aLewis, M M
700	1		_aMailman, R B
700	1		_aWainscott, D B
700	1		_aNelson, D L
700	1		_aNichols, D E
773	0		_tJournal of medicinal chemistry _gvol. 41 _gno. 12 _gp. 2134-45
856	4	0	_uhttps://doi.org/10.1021/jm980076u _zAvailable from publisher's website
999			_c9588964 _d9588964